Research work · 2014

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Hansjochen Wilke, Kei Muro, Eric Van Cutsem, Sang-Cheul Oh, Gyorgy Bodoky, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Oleg Nikolaevich Lipatov, Tae‐You Kim, David Cunningham, Philippe R Rougier, Yoshito Komatsu, Jaffer A. Ajani, Michael Emig, Roberto Massimo Carlesi, David Raymond Ferry, Kumari Chandrawansa, Jonathan D. Schwartz, Atsushi Ohtsu

The Lancet Oncology

DOI: 10.1016/s1470-2045(14)70420-6